Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Yee Chung Cheng MD

Yee Chung Cheng MD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center

View Curriculum Vitae

Publications (21)

  • Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection. (Pierro M, Zurko J, Szabo A, Cheng YC, Kamaraju S, Burfeind J, Retseck J, Chitambar CR, Chaudhary LN) WMJ 2023 Dec;122(5):418-421 PMID: 38180937 SCOPUS ID: 2-s2.0-85181850540 01/05/2024       1 Citation
  • Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy. (Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H) Breast Cancer Res Treat 2023 Oct;201(3):387-396 PMID: 37460683 PMCID: PMC10795510 SCOPUS ID: 2-s2.0-85164922339 07/18/2023       2 Citations
  • Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy. (Chaudhary LN, Jorns J, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo M, Kong A, Patten C, Yen T, Cortina C, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H) Res Sq 2023 Apr 07 PMID: 37066270 PMCID: PMC10104267 04/18/2023    
  • Metaplastic Breast Cancer: Characteristics and Survival Outcomes. (Thapa B, Arobelidze S, Clark BA, Xuefei J, Daw H, Cheng YC, Patel M, Spiro TP, Haddad A) Cureus 2022 Aug;14(8):e28551 PMID: 36185859 PMCID: PMC9517584 10/04/2022    
  • Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study. (Sridhar N, Glisch C, Jawa Z, Chaudhary LN, Kamaraju S, Burfeind J, Charlson J, Chitambar CR, Jorns JM, Cheng YC) J Cancer 2022;13(8):2472-2476 PMID: 35711833 PMCID: PMC9174868 SCOPUS ID: 2-s2.0-85130459904 06/18/2022       4 Citations
  • Establishing an interdisciplinary research team for cardio-oncology artificial intelligence informatics precision and health equity. (Brown SA, Sparapani R, Osinski K, Zhang J, Blessing J, Cheng F, Hamid A, Berman G, Lee K, BagheriMohamadiPour M, Lal JC, Kothari AN, Caraballo P, Noseworthy P, Johnson RH, Hansen K, Sun LY, Crotty B, Cheng YC, Olson J, Cardio-Oncology Artificial Intelligence Informatics & Precision (CAIP) Research Team Investigators) Am Heart J Plus 2022 Jan;13 PMID: 35434676 PMCID: PMC9012235 SCOPUS ID: 2-s2.0-85146432200 04/19/2022       13 Citations
  • A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores. (Fujii T, Masuda H, Cheng YC, Yang F, Sahin AA, Naoi Y, Matsunaga Y, Raghavendra A, Sinha AK, Fernandez JRE, James A, Yamagishi K, Matsushima T, Schuetz R, Tripathy D, Tada S, Jackson RS, Noguchi S, Nakamura S, Acoba JD, Ueno NT) Breast Cancer Res Treat 2021 Sep;189(2):455-461 PMID: 34131830 SCOPUS ID: 2-s2.0-85108015610 06/17/2021       6 Citations
  • Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer. (Kamaraju S, Fowler AM, Weil E, Wisinski KB, Truong TH, Lehr M, Chaudhary LN, Cheng YC, Chitambar CR, Rui H, Yee D, Lange C) Endocrinology 2021 Aug 01;162(8) PMID: 33735382 SCOPUS ID: 2-s2.0-85111784651 03/19/2021       7 Citations
  • Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ? (Chaudhary LN, Jawa Z, Hanif A, Szabo A, Kamaraju S, Cheng YC, Chitambar CR) WMJ 2018 Jun;117(2):62-67 PMID: 30048574 SCOPUS ID: 2-s2.0-85051516380 07/27/2018       5 Citations
  • Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation. (Cheng YC, Shi Y, Zhang MJ, Brazauskas R, Hemmer MT, Bishop MR, Nieto Y, Stadtmauer E, Ayash L, Gale RP, Lazarus H, Holmberg L, Lill M, Olsson RF, Wirk BM, Arora M, Hari P, Ueno N) J Cancer 2017;8(6):1009-1017 PMID: 28529613 PMCID: PMC5436253 SCOPUS ID: 2-s2.0-85017280753 05/23/2017       8 Citations
  • Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling. (Dong L, Yuan Y, Opansky C, Chen Y, Aguilera-Barrantes I, Wu S, Yuan R, Cao Q, Cheng YC, Sahoo D, Silverstein RL, Ren B) Oncotarget 2017 Apr 04;8(14):22550-22562 PMID: 28186980 PMCID: PMC5410244 SCOPUS ID: 2-s2.0-85016933174 02/12/2017       28 Citations
  • A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer. (Yao X, Hosenpud J, Chitambar CR, Charlson J, Cheng YC) J Cancer 2012;3:145-51 PMID: 22481980 PMCID: PMC3319980 SCOPUS ID: 2-s2.0-84881202664 04/07/2012       11 Citations
  • Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients. (Cheng YC, Takagi M, Milbourne A, Champlin RE, Ueno NT) Oncologist 2012;17(2):233-8 PMID: 22282904 PMCID: PMC3286172 SCOPUS ID: 2-s2.0-84857415514 01/28/2012       27 Citations
  • Improvement of survival and prospect of cure in patients with metastatic breast cancer. (Cheng YC, Ueno NT) Breast Cancer 2012 Jul;19(3):191-9 PMID: 21567170 PMCID: PMC3860359 SCOPUS ID: 2-s2.0-84866367880 05/14/2011       58 Citations
  • Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients. (Cheng YC, Valero V, Davis ML, Green MC, Gonzalez-Angulo AM, Theriault RL, Murray JL, Hortobagyi GN, Ueno NT) Br J Cancer 2010 Oct 26;103(9):1331-4 PMID: 20877352 PMCID: PMC2990606 SCOPUS ID: 2-s2.0-77958563900 09/30/2010       8 Citations
  • Carboplatin and docetaxel-induced acute pancreatitis: brief report. (Singh V, Devata S, Cheng YC) Int J Clin Oncol 2010 Dec;15(6):642-4 PMID: 20602134 SCOPUS ID: 2-s2.0-78651098095 07/06/2010       12 Citations
  • Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. (Cheng YC, Rondón G, Sanchez LF, McMannis JD, Couriel DR, de Lima MJ, Hosing C, Khouri IF, Giralt SA, Champlin RE, Ueno NT) Int J Hematol 2009 Dec;90(5):627-634 PMID: 19998065 SCOPUS ID: 2-s2.0-73449120674 12/10/2009       5 Citations
  • Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer. (de Souza JA, Davis ML, Rondon G, Cheng YC, Jones RB, Champlin RE, Ueno NT) Bone Marrow Transplant 2009 Jul;44(2):81-7 PMID: 19448681 SCOPUS ID: 2-s2.0-68149117281 05/19/2009       9 Citations
  • Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report. (Flejsierowicz M, Ahmed MS, Kotov P, Cheng YC) WMJ 2008 Jul;107(4):191-4 PMID: 18702436 SCOPUS ID: 2-s2.0-46849090934 08/16/2008       8 Citations
  • Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma. (Ahmed MS, Kroft SH, Davis NB, King DM, Cheng YC) Leuk Res 2008 Sep;32(9):1476-9 PMID: 18308388 SCOPUS ID: 2-s2.0-43049180001 03/01/2008       5 Citations
  • Primary mediastinal embryonal carcinoma masquerading as chronic pancreatitis. (Kaikobad M, Cheng YC, Choi H, Teves D) WMJ 2007 Jul;106(4):225-8 PMID: 17844714 SCOPUS ID: 2-s2.0-34548287492 09/12/2007       1 Citation
    • Last update: 04/11/2024